Science Explorer Interactive view Map
Company · Menlo Park · United States

TrueBinding (United States)

truebinding.comROR OpenAlex
Research works
14
▲ 165% vs 2013–17
Citations
151
10.9 per fractional work
Top-10% rate
12.8%
record average 16.5%
Open access
49%
world 28%

Not ranked overall: TrueBinding (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 6.92× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 25.56× its world share, 2 worksImmunology and Micro…Neuroscience: 7.92× its world share, 1 worksNeuroscienceComputer Science: 0.99× its world share, 1 worksComputer ScienceEngineering: 0.13× its world share, 0 worksEngineeringEnvironmental Science: 0.10× its world share, 0 worksEnvironmental ScienceMedicine: 0.51× its world share, 1 worksMedicinePsychology: 0.84× its world share, 0 worksPsychologySocial Sciences: 0.15× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 25.6×. Every wedge is a field page.

Which research topics does TrueBinding (United States) publish most on?

By volume in 2022–2025: Galectins and Cancer Biology, Glycosylation and Glycoproteins Research, Cancer Research and Treatments and Nuclear Receptors and Signaling.

Galectins and Cancer Bio…2Galectins and Cancer Biology: 2 fractional worksGlycosylation and Glycop…2Glycosylation and Glycoproteins Research: 2 fractional worksCancer Research and Treatments: 1 fractional worksNuclear Receptors and Si…1Nuclear Receptors and Signaling: 1 fractional worksEducational Technology a…0Educational Technology and Assessment: 0 fractional worksSignaling Pathways in Di…0Signaling Pathways in Disease: 0 fractional worksCurcumin's Biomedical Applications: 0 fractional worksImmune cells in cancer: 0 fractional worksGlioma Diagnosis and Treatment: 0 fractional worksCircular RNAs in diseases: 0 fractional works
ImmunologyMolecular BiologyBiotechnologyCellular and Molecular Neuroscience3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Galectins and Cancer Biology Immunology 2 works
  2. 2 Glycosylation and Glycoproteins Research Molecular Biology 2 works
  3. 3 Cancer Research and Treatments Biotechnology 1 works
  4. 4 Nuclear Receptors and Signaling Cellular and Molecular Neuroscience 1 works
  5. 5 Educational Technology and Assessment Information Systems 0 works
  6. 6 Signaling Pathways in Disease Molecular Biology 0 works
  7. 7 Curcumin's Biomedical Applications Molecular Medicine 0 works
  8. 8 Immune cells in cancer Immunology 0 works
  9. 9 Glioma Diagnosis and Treatment Genetics 0 works
  10. 10 Circular RNAs in diseases Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.9%not open51.1%

World: 28% of research is openly available.

with international co-authors15.6%domestic only84.4%

World: 19% is written across borders.

How has TrueBinding (United States)'s research output changed?

Output in 2018–2022 was 165% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Menlo Park

All research institutions in Menlo Park

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.